FDA Said Human Genome Sciences' Anthrax Drug Successfully Treated Animals (HGSI)
Fri. October 23, 2009; Posted: 11:53 AM
Oct 23, 2009 (SmarTrend(R) News Watch via COMTEX) --
HGSI |
Quote |
Chart |
News |
PowerRating -- 10/23/2009 - The FDA said Human Genome Sciences' ABthrax (NASDAQ:HGSI) successfully treated animals that had been exposed to anthrax. The company asked the FDA to approve the inhalable drug to treat the toxin once it has entered the bloodstream, but the FDA still has questions about its use in humans because animal studies do not always predict success in human studies. The United States government has already ordered around 60,000 doses for its emergency stockpile. The panel that reviewed the drug said that it appeared to be effective when used with antibiotics in rabbits and monkeys.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Human Genome Sciences (HGSI)
click here. Human Genome Sciences (HGSI) has Short Term PowerRatings of 4. Details on Human Genome Sciences (HGSI) Short Term PowerRatings is available at
This Link.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index